Nf-κB protects HIV-1-infected myeloid cells from apoptosis

Virology

Volumn 244, Issue 1, 1998, Pages 27-38

  Deluca, Carmela ^a,b   Kwon, Hakju ^a,b   Pelletier, Nadine ^a,b   Wainberg, Mark A ^a,b   Hiscott, John ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; BAX PROTEIN, HUMAN; DNA BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL PROTECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DNA-BINDING PROTEINS; HIV-1; HUMANS; I-KAPPA B PROTEINS; JURKAT CELLS; MONOCYTES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0032565144     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9085     Document Type: Article

References (66)

1. Abbadie C., Kabrun N., Bouali F., Smardova J., Stehelin D., Vandenbunder B., Enrietto P. J. High levels of c-Rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cellsin vitro. Cell. 75:1993;899-912.
2. Aillet F., Gourgerot-Pocidalo M. A., Virelizier J. L., Israël N. Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation. AIDS Res. Hum. Retroviruses. 10:1994;405-411.
3. Ameisen J., Estaquier J., Idziorek T., DeBels F. The relevance of apoptosis to AIDS pathogenesis. Trends Cell Biol. 5:1995;27-32.
4. Arai K. -I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:1990;783-836.
5. Arenzana-Seisdedos F., Thompson J., Rodriguez M. S., Bachelerie F., Thomas D., Hay R. T. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and the transcriptional activities of NF-κB. Mol. Cell. Biol. 15:1995;2689-2696.
6. Bachelerie F., Alcami J., Arenzana-Seisdedos F., Virelizier J.-L. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature. 350:1991;709-712.
7. Baeuerle P. A., Baltimore D. NF-κB: Ten years after. Cell. 87:1996;13-20.
8. Baichwal V. R., Baeuerle P. A. Apoptosis: Activate NF-κB or die. Curr. Biol. 7:1997;R94-R96.
9. Baldwin A. S. Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681.
10. Beg A. A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
11. Cai Z., Korner M., Tarantino N., Chouaib S. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α induced apoptosis. J. Biol. Chem. 272:1997;96-101.
12. Chang H. -K., Gallo R. C., Ensoli B. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J. Biomed. Sci. 2:1995;189-202.
13. Chen Z. J., Parent L., Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
14. Chu C. -H., McKinsey T., Liu L., Gentry J., Malim M., Ballard D. W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA. 94:1997;10057-10062.
15. D'Addario M., Wainberg M. A., Hiscott J. Activation of cytokine genes in HIV-1 infected myelomonoblastic cells by phorbol ester and tumor necrosis factor. J. Immunol. 148:1992;1222-1229.
16. Dbaido G. S., Perry D. K., Gamard C. J., Platt R., Poirier G. G., Obeid L. M., Hannun Y. A. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:1997;481-490.
17. DeLuca C., Roulston A., Koromilas A., Wainberg M. A., Hiscott J. Chronic human immunodeficiency virus type I infection of myeloid cells disrupts the autoregulatory control of the NF-κB/Rel pathway via enhanced IκBα degradation. J. Virol. 70:1996;5183-5193.
18. Demarchi F., d'Adda di Fagagna F., Falaschi A., Giacca M. Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70:1996;4427-4437.
19. DeRossi A., Ometto L., Roncella S., D'Andrea E., Menin C., Calderazzo F., Rowe M., Ferrarini M., Chieco-Bianchi L. HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: Model for a persistent "self-limiting" HIV-1 infection. Virology. 198:1994;234-244.
20. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
21. Garaci E., Palamara A. T., Ciriolo M. R., D'Agostini C., Ab del-Latif M. S., Aquaro S., Lafavia E., Rotilio G. Intracellular GSH and HIV replication in human macrophages. J. Leukocyte Biol. 62:1997;54-59.
22. Grimm S., Bauer M. K., Baeuerle P. A., Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-kappa B induced upon apoptosis. J. Biol. Chem. 134:1996;13-23.
23. Herbein G., van Lint C., Lovett J. L., Verdin E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 72:1998;660-670.
24. Hsu H., Shu H., Pan M., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
25. Ivanov V. N., Lee R. K., Rodack E. R., Malek T. R. Regulation of Fas-denpendent activation-induced T cell apoptosis by cAMP signaling: A potential role for transcription factor NF-kappa B. Oncogene. 14:1997;2455-2464.
26. Jaattela M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signalling. J. Immunol. 156:1996;1166-1173.
27. Jaffray E., Wood K. M., Hay R. T. Domain organization of IκBα and the sites of interaction with NF-κB p65. Mol. Cell. Biol. 15:1995;2166-2172.
28. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκBα Science. 268:1995;1619-1621.
29. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1081-1082.
30. Kwon H., Cisternas S., DeLuca C., Pelletier N., Genin P., Lin R., Wainberg M. A., Hiscott J. Inducible expression of IκBα repressor mutants interferes with NF-κB activity of HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273:1998.
31. Lacoste J., D'Addario M., Roulston A., Wainberg M. A., Hiscott J. Cell-specific differences in activation of NF-κB regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor. J. Virol. 64:1990;4726-4734.
32. Lee R., Beauparlant P., Elford H., Ponka P., Hiscott J. Selective inhibition of IκBα phosphorylation and HIV LTR directed gene expression by novel antioxidnat compounds. Virology. 234:1997;277-290.
33. Lenardo M. J., Baltimore D. NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
34. Lin K. I., Lee S. H., Narayanan R., Baraban J. M., Hardwick J. M., Ratan R. R. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell. Biochem. 131:1995;1149-1161.
35. Lipton S. A. Janus faces of NF-kappa B: Neurodestruction versus neuroprotection. Nature Med. 3:1997;20-22.
36. Maldarelli F., Sato H., Berthold E., Orenstein J., Martin M. A. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J. Virol. 69:1995;6457-6465.
37. Marianneau R., Cardona A., Edelman L., Deubel V., Despres P. Dengue virus replication in human hepatoma cells activates NF-kappa B which in turn induces apoptotic cell death. J. Virol. 71:1997;3244-3249.
38. McElhinny J. A., MacMorran W. S., Bren G. D., Ten R. M., Israel A., Paya C. V. Regulation of IκBα and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J. Virol. 69:1995;1500-1509.
39. Mercurio F., Zhu H., Murray B. W., Shevchenko A., Bennett B. L., Li J. W., Young D. B., Barbosa M., Mann M. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866.
40. Nottet H. S. L. M., Moelans I. I. M. D., de Vos N. M., de Graaf L., Visser M. R., Verhoef J. N-acetyl-L-cysteine-induced up-regulation of HIV-1 gene expression in monocyte-derived macrophages correlates with increased NF-κB DNA binding activity. J. Leukocyte Biol. 61:1997;33-38.
41. Pepin N., Roulston A., Lacoste J., Lin R., Hiscott J. Subcellular redistribution of HTLV-1-Tax protein by NF-κB/Rel transcription factors. Virology. 204:1994;706-716.
42. Perno C. F., Crowe S. M., Kornbluth R. S. HIV and cells of macrophage lineage. J. Leukocyte Biol. 62:1997;1-143.
43. Poli G., Kinter A., Justement J. S., Kehrl J. H., Bressler P., Stanley S., Fauci A. S. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA. 87:1990;782-785.
44. Reed J. C., Miyashita T., Takayama S., Wang H. G., Sato T., Krajewski S., Aime-Sempe C., Bodrug S., Kitada S., Hanada M. Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60:1996;23-32.
45. Régnier C., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
46. Roederer M., Staal F. J., Raju P. A., Ela S. W., Herzenberg L. A. Cytokine-stimulated human immunodeficiency virus replication is inhibited byN-acetyl-L-cysteine. Proc. Natl. Acad. Sci. USA. 87:1990;4884-4888.
47. Roederer M., Raju P. A., Staal F. J., Herzenberg L. A. N-Acetyl-L-cysteine inhibits latent HIV expression in chronically infected cells. AIDS Res. Hum. Retroviruses. 7:1991;563-567.
48. Roulston A., D'Addario M., Boulerice F., Caplan S., Wainberg M., Hiscott J. Induction of monocytic differentiation and NF-κB-like activities by human immunodeficiency virus-1 infection of human myelomonoblastic cells. J. Exp. Med. 175:1992;751-763.
49. Roulston A., Beauparlant P., Rice N. R., Hiscott J. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-κB/rel DNA binding activities in myelomonoblastic cells. J. Virol. 67:1993;5235-5246.
50. Roulston A., Lin R., Beauparlant P., Wainberg M. A., Hiscott J. Regulation of HIV-1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:1995;481-505.
51. Sastry K. J., Marin M. C., Nehete P. N., McConnell K., El-Naggar A. K., McDonnell T. J. Expression of human immunodeficiency virus type I tat results in downregulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene. 13:1996;487-493.
52. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
53. Staal F. J. T., Roederer M., Raju P. A., Anderson M. T., Ela S. W., Herzenberg L. A. Antioxidants inhibit stimulation of HIV transcription. AIDS Res. Hum. Retroviruses. 9:1993;299-306.
54. Strack P. R., Frey M. W., Rizzo C. J., Cordova B., George H. J., Meade R., Ho S. P., Corman J., Tritch R., Korant B. D. Apoptosis is mediated by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA. 93:1996;9571-9576.
55. Tewari M., Dixit V. M. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6:1996;39-44.
56. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
57. Verma I. M., Stevenson J. K., Schwarz E. M., Antwerp D. V., Miyamoto S. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev. 9:1995;2723-2735.
58. Wang C. Y., Mayo M. W., Baldwin A. S. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
59. Whiteside S. T., Epinat J. C., Rice N. R., Israel A. I kappa B epilson, a novel member of the Ikappa B family, controls RelA and c-Rel NF-kappa B activity. EMBO J. 16:1997;1413-1426.
60. Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science. 278:1997;866-869.
61. Wu B. Y., Woffendin C., MacLachlan I., Nabel G. J. Distinct domains of IκB-alpha inhibit human immunodeficiency virus type 1 replication through NF-κB and Rev. J. Virol. 71:1997;3161-3167.
62. Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., FitzGerald M. J., Rothstein T. L., Sherr D. H., Sonenshein G. E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
63. Yang E., Korsmeyer S. J. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood. 88:1996;386-401.
64. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
65. Zauli G., Gibellini D., Caputo A., Bassini A., Negrini M., Monne M., Mazzoni M., Capitani S. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood. 86:1995;3823-3834.
66. Zauli G., Gibellini D. The HIV-1 Tat protein and Bcl-2 gene expression. Leuk. Lymph. 23:1996;551-560.